VivoSim Labs VIVS
NASDAQ VIVS
$0.26 0.00 (-0.27%)
As of: Sep 17, 2026 · 3:59 PM EDT

VivoSim Labs (VIVS) Other Operating Expenses (2010 - 2024)

VivoSim Labs (VIVS) posted Other Operating Expenses of $2000.0 for Q4 2024, up 100.0% on a QoQ basis from $1000.0 in Q3 2024.

Analysis

VivoSim Labs (VIVS) Other Operating Expenses (2010 - 2024) Analysis & Trends

VivoSim Labs has reported Other Operating Expenses for 12 years, with the latest figure at $2000.0 in Q4 2024.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $2000.0 in Q4 2024; TTM through Sep 2025 was $2000.0, a 33.33% decrease from a year earlier, with the FY2025 full-year figure at $10.0 million, changed N/A from the prior year.
  • Other Operating Expenses was $2000.0 for Q4 2024 at VivoSim Labs, up from $1000.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $6000.0 in Q2 2020, with the low at -$20000.0 in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 2,000.00
Sep 30, 2024 1,000.00
Jun 30, 2024 2,000.00
Dec 31, 2020 -20,000.00
Sep 30, 2020 -5,000.00
Jun 30, 2020 6,000.00
Dec 31, 2019 525,000.00
Sep 30, 2019 85,000.00
Jun 30, 2019 1,000.00
Dec 31, 2018 -65,000.00
Jun 30, 2018 2,000.00
Mar 31, 2018 4,000.00
Mar 31, 2017 183,000.00
Dec 31, 2016 212,000.00
Sep 30, 2016 393,000.00
Jun 30, 2016 168,000.00
Mar 31, 2015 -9,000.00
Sep 30, 2014 -3,000.00
Sep 30, 2013 -4,000.00
Jun 30, 2013 -4,000.00